Skip to main content
. 2015 Sep 14;210(6):991–1002. doi: 10.1083/jcb.201502029

Figure 6.

Figure 6.

Sortilin and PSAP comprise two independent and complementary pathways for PGRN lysosomal targeting. (A) Immunoblot for sortilin with lysates prepared from fibroblasts and N2a cells. Gapdh was used as a loading control. (B) Immunostaining for PGRN, LAMP1, and PSAP in fibroblasts derived from wild-type and Sort1−/− mice. (C) Ectopic expression of sortilin in PSAP−/− fibroblasts rescues the PGRN trafficking defect. PSAP−/− fibroblasts were transfected with GFP-sortilin. 48 h after transfection, the cells were fixed and stained with sheep anti–mouse PGRN and rabbit anti–Cathepsin D. Representative images from three replicated experiments are shown. Bars: (main) 20 µm; (inset) 5 μm.